United Community Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-600
Closed -$55.4K – 371
2024
Q2
$55.4K Hold
600
– – 0.02% 291
2024
Q1
$57.3K Hold
600
– – 0.02% 274
2023
Q4
$45.8K Hold
600
– – 0.02% 293
2023
Q3
$41.6K Buy
+600
New +$48.2K 0.02% 269
2023
Q2
– Sell
-165
Closed -$13.7K – 233
2023
Q1
$13.7K Hold
165
– – 0.01% 205
2022
Q4
$12.3K Hold
165
– – 0.01% 229
2022
Q3
$13.6K Hold
165
– – 0.01% 220
2022
Q2
$15.7K Hold
165
– – 0.02% 217
2022
Q1
$19.4K Hold
165
– – 0.02% 205
2021
Q4
$21.4K Buy
+165
New +$19.2K 0.02% 205

Other funds holding EW

United Community Bank's EW Position: Q3 2024 in Review

United Community Bank sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 600 shares — an estimated $55.4K sold.

United Community Bank first reported a position in EW in Q4 2021 and held it in 10 quarters. The position peaked at $57.3K in Q1 2024. 1,195 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • United Community Bank reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • United Community Bank sold 600 Edwards Lifesciences shares in Q3 2024, an estimated $55.4K.
  • United Community Bank first reported a position in Edwards Lifesciences in Q4 2021 and held it in 10 quarters.
  • United Community Bank's Edwards Lifesciences position peaked at $57.3K in Q1 2024.
  • 1,195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on United Community Bank's 13F filing for Q3 2024, filed 30 Oct 2024.